Comparison of68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome

Comparison of68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome

The optimum imaging modality for the screening of multiple endocrine neoplasia type 1 (MEN1)-associated tumors is not well established. Here, we compare the performance of contrast-enhanced CT (CECT) versus68Ga DOTA-NOC/TATE PET/CT in MEN1 patients. The retrospective case record study is conducted a...

Full description

Bibliographic Details
Main Authors: Virendra A Patil, Manjunath R Goroshi, Hina Shah, Gaurav Malhotra, Priya Hira, Vijaya Sarathi, Vikram R Lele, Swati Jadhav, Anurag Lila, Tushar R Bandgar, Nalini S Shah
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:World Journal of Nuclear Medicine
Subjects:
68ga-dota-nai3-octreotide/tyr3-octreotate positron emission tomography/computed tomography
contrast enhanced computed tomography
gastrointestinal-pancreatic neuroendocrine tumor
multiple endocrine neoplasia type 1 imaging
multiple endocrine neoplasia type 1 syndrome
Online Access:http://www.wjnm.org/article.asp?issn=1450-1147;year=2020;volume=19;issue=2;spage=99;epage=105;aulast=Patil

Internet

http://www.wjnm.org/article.asp?issn=1450-1147;year=2020;volume=19;issue=2;spage=99;epage=105;aulast=Patil

Similar Items